Structure of Pycnonodysostosis disease related I249T mutant of human cathepsin K | | homo-2-mer | 16-329 | 8×GOL; 16×EDO; 5×SO4; 7×PEG; 1×CL; 1×NA; 3×MPD; |
Assess |
CRYSTAL STRUCTURE OF WILD TYPE HUMAN PROCATHEPSIN K | | homo-2-mer | 16-329 | |
Assess |
Structure of the activation intermediate of cathepsin K in complex with the 3-cyano-3-aza-beta-amin… | | homo-2-mer | 23-329 | 1×A0U; 1×ACT; 1×MG; |
Assess |
Structure of the activation intermediate of cathepsin K in complex with the azadipeptide nitrile in… | | homo-2-mer | 23-329 | 1×9ZG; 3×EDO; 1×CL; 1×MG; |
Assess |
The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Ca… | | homo-2-mer | 115-329 | 2×HVW; 1×CA; 2×CL; |
Assess |
Cathepsin K complexed with a ketoamide inhibitor | | homo-2-mer | 115-329 | 3×SO4; 2×FSP; |
Assess |
Crystal structure of the cathepsin K : chondroitin sulfate complex. | | homo-2-mer | 115-329 | 2×BDP; 2×CA; 2×E64; |
Assess |
THE CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN K | | monomer | 20-329 | |
Assess |
Human cathepsin K mutant C25S in complex with the allosteric effector NSC13345 | | monomer | 107-329 | 1×1XF; 1×SO4; |
Assess |
Human cathepsin K mutant C25S in complex with the allosteric effector NSC94914 | | monomer | 108-329 | 1×6HM; 1×SO4; |
Assess |
Structure of cathepsin K in complex with the azadipeptide nitrile inhibitor Gu1303 | | monomer | 113-329 | 1×9ZG; 1×CL; 1×ACT; |
Assess |
Cathepsin-K in complex with MIV-711 | | monomer | 113-329 | 1×J5N; 6×NO3; |
Assess |
Cathepsin-K in complex with MIV-701 | | monomer | 114-329 | 1×HFH; 1×GOL; 1×NA; |
Assess |
Structure of human cathepsin K in complex with the selective activity-based probe Gu3416 | | monomer | 114-329 | 1×SO4; 1×UUW; |
Assess |
Structure of human cathepsin K in complex with the acrylamide inhibitor Gu3110 | | monomer | 114-329 | 1×SO4; 1×UUK; |
Assess |
Cathepsin-K in complex with amino-oxaazabicyclo[3.3.0]octanyl containing inhibitor | | monomer | 114-329 | 1×MHA; 1×J6B; |
Assess |
Crystal structure of a pyrrolopyrimidine inhibitor in complex with human Cathepsin K | | monomer | 114-329 | 1×CKE; |
Assess |
Cathepsin-K in complex with MIV-710 | | monomer | 114-329 | 1×J5T; 3×CL; 1×NA; |
Assess |
Crystal Structure of the Cysteine Protease Human Cathepsin K in Complex with the Covalent Inhibitor… | | monomer | 114-329 | 1×IHJ; |
Assess |
Cathepsin-K in complex with fluoro-oxa-azabicyclo[3.3.0]octanyl containing inhibitor | | monomer | 114-329 | 1×HKH; |
Assess |
Crystal Structure of the Cysteine Protease Human Cathepsin K in Complex with the Covalent Inhibitor… | | monomer | 114-329 | 1×IHI; |
Assess |
Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inh… | | monomer | 115-329 | 1×3XT; 1×I37; 6×SO4; |
Assess |
Crystal structure of Cathepsin K with a covalently-linked inhibitor at 1.4 Angstrom resolution. | | monomer | 115-329 | 1×7AS; |
Assess |
Crystal structure of human Cathepsin K with a non-active site inhibitor at 1.42 Angstrom resolution | | monomer | 115-329 | 3×1XF; |
Assess |
Cathepsin K in complex with a non-selective 2-cyano-pyrimidine inhibitor | | monomer | 115-329 | 6×SO4; 1×KWZ; |
Assess |
Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inh… | | monomer | 115-329 | 1×GOL; 1×CL; 1×K; 3×PGO; 1×3Y2; |
Assess |
Crystal structure of uninhibited human Cathepsin K at 1.62 Angstrom resolution | | monomer | 115-329 | |
Assess |
Cathepsin K inhibitor | | monomer | 115-329 | 1×0LC; 2×SO4; |
Assess |
Cathepsin K covalently bound to a 2-cyano pyrimidine inhibitor with a benzyl P3 group. | | monomer | 115-329 | 2×SO4; 1×O75; |
Assess |
Cathepsin K inhibitor | | monomer | 115-329 | 1×0LB; 1×GOL; |
Assess |
Cathepsin K covalently bound to a cyano-pyrimidine inhibitor with improved selectivity over hERG | | monomer | 115-329 | 1×O47; |
Assess |
X-ray structure of Cathepsin K covalently bound to a triazine ligand | | monomer | 115-329 | 1×ORG; 1×TFA; |
Assess |
Crystal structure of Cathepsin K complexed with a potent vinyl sulfone inhibitor | | monomer | 115-329 | 1×0D6; |
Assess |
Structure of human Cathepsin K with an ectosteric inhibitor at 1.85 Angstrom resolution | | monomer | 115-329 | 4×J0V; |
Assess |
Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inh… | | monomer | 115-329 | 1×3Y1; 5×SO4; |
Assess |
Structure of cathepsin K in complex with the 3-cyano-3-aza-beta-amino acid inhibitor Gu2602 | | monomer | 115-329 | 1×A0U; |
Assess |
Cathepsin K complexed with a pyrrolidine ketoamide-based inhibitor | | monomer | 115-329 | 1×4PR; |
Assess |
Crystal structure of a potent small molecule inhibitor bound to cathepsin K | | monomer | 115-329 | 1×NFT; |
Assess |
Crystal structure of Human Cathepsin K in complex with myocrisin | | monomer | 115-329 | 1×SO4; 1×MYQ; |
Assess |
Sulfonated Calpeptin is a promising drug candidate against SARS-CoV-2 infections | | monomer | 115-329 | 1×CA; |
Assess |
Structure of CatK covalently bound to a dioxo-triazine inhibitor | | monomer | 115-329 | 1×ORH; |
Assess |
Cathepsin K complexed with t-butyl(1S)-1-cyclohexyl-2-oxoethylcarbamate | | monomer | 115-329 | 1×SO4; 1×TCO; |
Assess |
CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT SYMMETRIC BISCA… | | monomer | 115-329 | 1×INA; |
Assess |
CRYSTAL STRUCTURE OF CATHEPSIN K WITH N-DESMETHYL THALASSOSPIRAMIDE C | | monomer | 115-329 | 1×G4B; |
Assess |
CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR… | | monomer | 115-329 | 1×E64; |
Assess |
Crystal Structure of the Cysteine Protease Human Cathepsin K in Complex with the Covalent Inhibitor… | | monomer | 115-329 | 1×IHE; |
Assess |
The crystal structure of the cathepsin K Variant M5 in complex with chondroitin-4-sulfate | | monomer | 115-329 | 1×BDP; 1×CA; 1×E64; |
Assess |
CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT THIAZOLHYDRAZID… | | monomer | 115-329 | 1×IN6; |
Assess |
Cathepsin K complexed with a semicarbazone inhibitor | | monomer | 115-329 | 3×SO4; 1×CT2; |
Assess |
CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PEPTIDOMIMETIC … | | monomer | 115-329 | 1×I10; |
Assess |
CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PYRROLIDINO… | | monomer | 115-329 | 1×INP; |
Assess |
CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT BENZYLOXYBENZOY… | | monomer | 115-329 | 1×IN3; |
Assess |
CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT AZEPANONE I… | | monomer | 115-329 | 1×2CA; |
Assess |
CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PYRROLIDINO… | | monomer | 115-329 | 1×PCM; |
Assess |
Cathepsin K complexed with a cyanopyrrolidine inhibitor | | monomer | 115-329 | 1×NBL; |
Assess |
CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT SYMMETRIC D… | | monomer | 115-329 | 1×SDK; |
Assess |
CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PROPANONE I… | | monomer | 115-329 | 1×POS; |
Assess |
Structure of Cathepsin K-dermatan sulfate complex | | monomer | 115-329 | 1×ASG; |
Assess |
Crystal Structure Of The Cysteine Protease Human Cathepsin K In Complex With A Covalent Azepanone I… | | monomer | 115-329 | 1×750; |
Assess |
Human cathepsin K mutant C25S | | monomer | 116-329 | 2×SO4; 1×ACT; 1×CL; |
Assess |
Cathepsin K complexed with a constrained ketoamide inhibitor | | monomer | 116-329 | 2×SO4; 1×3FC; |
Assess |
Cathepsin K complexed with carbamate derivatized norleucine aldehyde | | monomer | 116-329 | 3×SO4; 1×MYE; |
Assess |
Cathepsin K in complex with a selective 2-cyano-pyrimidine inhibitor | | monomer | 117-329 | 1×KX1; 2×SO4; |
Assess |
Cathepsin K co-crystallized with actinomycetes extract | | monomer | 117-329 | 1×SO4; |
Assess |
Crystal structure of cathepsin K bound to the covalent inhibitor lichostatinal | | monomer | 117-329 | 3×SO4; |
Assess |
cathepsin K - chondroitin sulfate complex | | monomer | 117-329 | 1×BDP; |
Assess |
Cathepsin K complexed with a semicarbazone inhibitor | | monomer | 117-329 | 1×CT1; |
Assess |
Cathepsin K complexed with a cyanamide-based inhibitor | | monomer | 117-329 | 1×T2M; |
Assess |
Cathepsin K in complex with a covalent inhibitor with a ketoamide warhead | | monomer | 121-329 | 1×O96; 2×SO4; |
Assess |